Similarly, increased extracellular DA (i.e. lower [18F]DOPA influx/DAT binding/receptor binding) has been reported in the striatum (153, 163, 164) and midbrain (153, 158, 165) of ADHD patients relative to controls. Here, SLC6A3 is linked to attention deficit-hyperactivity disorder.